104 studies found for: Open Studies | "Hypercholesterolemia"
A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)
|2||Not yet recruiting||
A Study in Subjects With Type 2 Diabetes Mellitus With Hypercholesterolemia/Mixed Dyslipidemia
Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Study of Awareness and Detection of Familial Hypercholesterolemia
|5||Not yet recruiting||
Open Label Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Pediatric Subjects (10 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia (HeFH) or Homozygous Familial Hypercholesterolemia (HoFH).
The Spanish Familial Hypercholesterolaemia Cohort Study
Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe
French Observatory of Familial Hypercholesterolemia in Cardiology
Russian Familial Hypercholesterolemia Registry
Efficacy of a Red Yeast Rice Based Nutraceutical Plus Probiotic in Patients With Moderate Hypercholesterolemia
Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia
Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR)
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
Graves' Orbitopathy and Hypercholesterolemia
EFFECTS OF CARDICHOL, AN HERBAL DIETARY SUPPLEMENT, IN MODERATE HYPERCHOLESTEROLEMIA
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.
† Indicates status has not been verified in more than two years